Journal of Medical Economics

Title Publication Date Language Citations
The impact of economic factors on treatment results for tumor inpatients in the under-developed Western region of China2015/12/21English
Characterizing downstream healthcare resource utilization and costs based on prior utilization patterns of immediate-release hydrocodone2015/12/02English
Erratum2012/01/01English
Healthcare-related characteristics of low vs normal folate levels among women of child-bearing age2012/04/24English
Reply: Essential need for research in hepatitis C2015/04/24English
Re: Saunders R, Lian J, Karolicki B, Valentine W. The cost-effectiveness and budget impact of stepwise addition of bolus insulin in the treatment of type 2 diabetes: evaluation of the FullSTEP trial. J Med Econ 2014;17(12):827-362015/02/16English
Reply: Letter to the editor for FullSTEP BIA in JME by Saunders et al 20142015/02/09English
Response to the letter to the editor2012/09/07English
Letter to the Editor2012/08/24English
Letter to the editor2012/12/05English
Erratum2012/11/19English
Comparative effectiveness: beyond the buzz2012/11/19English
Introducing the JME Special Issue on Cost-Effectiveness Analyses2012/11/01English
Healthcare resource utilization and economic impact of a ≥2 g/dL decrease in hemoglobin in osteoarthritis patients2013/02/07English
Cost-effectiveness of TAVR in the non-surgical population2013/02/12English
Letter to the Editor2014/02/20English
Erratum2013/09/19English
Cost effectiveness analysis of a next generation risk assessment score for cardiovascular disease2013/12/12English
Low clinical adoption of tumor genomic profiling: cause for concern?2018/05/15English
Healthcare costs of fast-acting insulin analogues versus short-acting human insulin for Danish patients with type 2 diabetes on a basal–bolus regimen2011/01/01English
Cost and clinical consequences of stress/single-photon emission computed tomography testing with specific medications2011/01/01English
Increasing economic burden caused by nephro-geriatric patients2017/11/23English
The importance of model inputs and assumptions in conducting health technology assessments of novel drugs2017/08/04English
Reply: Global health resource utilization associated with pacemaker complications2018/01/15English
Reply to: Brough CEP, Haycox A. Resource Use In Rectifying Pacemaker Complications. Journal of Medical Economics 2018. doi: 10.1080/13696998.2017.14230752018/01/15English
The cost-effectiveness of zuranolone versus selective serotonin reuptake inhibitors for the treatment of postpartum depression in the United States2024/03/31English
Value of next generation sequencing (NGS) testing in advanced cancer patients2024/04/02English
Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan’s public healthcare system2024/04/08English
Economic burden of systemic lupus erythematosus in Malaysia2024/03/06English
Microsimulation model of the cost-effectiveness of anifrolumab compared to belimumab in the United Arab Emirates2024/03/06English